QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®
Titel:
QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®
Auteur:
Jaffar-Aghaei, Morteza Khanipour, Farzad Maghsoudi, Amir Sarvestani, Rahim Mohammadian, Mahdi Maleki, Maryam Havasi, Forugh Rahmani, Hossein Karagah, Amir-Hossein Kazemali, Mohammad-Reza